with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent as the internal reference.
HPLC purification for trans-cyclooctene triphosphate (TCO-TTP) was carried out using a Shimadzu LC-20AT VP system with a Zobax C18 reversed-phase column (9.4 mm × 25 cm).
The sample was eluted (3 mL/min) with buffer A (20 mM triethylammonium acetate, pH 6.9-7.1) and buffer B (50% acetonitrile, 20 mM triethyl ammonium acetate) with the following: 0 min 0% B; 20 min 20% B; 30 min 100% B; 38 min 100% B; 40 min 0% B; and 45 min 0% B.
DNA primers and templates were purchased from Integrated DNA Technologies. Klenow fragment (3'-5' exo), Taq. DNA polymerase and Deep VentR (exo-) DNA polymerase were purchased from New England Biolabs. KOD-XL DNA polymerase was purchased from EMD Chemicals. Reaction buffers were used as provided.
Experimental Procedure for the Synthesis of TCO-TTP
Compound 2 was prepared starting from cyclooctadiene (1) in four steps following literature procedures.
Compound 4 was synthesized starting from 5-odo-2'-deoxyuridine (3) in two steps following literature procedures. 2, 3 (E)-Cyclooct-4-en-1-yl (3-(1-((2R,4S,5R) 
To a mixture of succimidyl ester 2 (134 mg, 0.5 mmol) and amine modified deoxyuridine 4 (168 mg, 0.6 mmol) in DMF 10 mL was added DIPEA (129 mg, 1 mmol). The reaction mixture was wrapped in foil and stirred in r.t. for 12 h. Reaction solution was concentrated under reduced pressure and purified with silica gel chromatography (12% MeOH in DCM) to give a white solid (108 mg, yield 52%). The mixture was stirred at RT for 10 min and then triethylammonium bicarbonate solution (0.1 M, pH 8, 11 mL) was added. After stirring at r.t. for an additional 1 h, the resulting reaction mixture was transferred to a 50-mL centrifuge tube. Then EtOH (33 mL) was added followed by 3 M NaCl solution (1.0 mL). After vortexing for 10 sec, the centrifuge tube was placed at -80 o C for 1 h, and then centrifuged at 5000 rpm for 20 min. After removing the supernatant, the resulting pellet was purified by HPLC and lyophilized to give a pale white powder (32 mg, 32%). Compound 10 was prepared starting from pyrimidine-5-carbonitrile in three steps following literature procedures. 5 5-(3-(2-Aminoethyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid 11
Compound 11 was prepared starting from commercially available Fluorescein isothiocyanate (FITC) in one step following literature procedures. 
HPLC stability test
In addition to the NMR study, TCO thermo-stability was further examined with HPLC. As shown in Figure S2 
NMR Spectra of Synthesized Compounds (Please see next pages)

